Fresenius Medical Care AG & Co. KGaA

NYSE:FMS

Medical - Care Facilities

Healthcare
$20.95 -0.76%

-$0.18 today

Market cap
$11.26B
Beta
0.81
P/E (TTM)
11.9
EPS (TTM)
$3.43
Dividend yield
3.65%
52W Low $20.02High $28.87

Volume 1.92M

Average 0.72M

FMS Other Non-current Assets

Long-term assets not reported separately.

Fresenius Medical Care AG & Co. KGaANYSE: FMS

Other Non-current Assets · Q2 FY2026 · quarter ended Jun 2026

Other non-current assets rises 39.2% from a year ago

Other non-current assets stood at €296.47M at the end of Q2 FY2026, up 39.2% from a year earlier and up 27.0% from the prior quarter. Over 3 fiscal years it compounded at +95.7% a year.

Context

  • Other non-current assets amounted to 0.9% of total assets at the end of Q2 FY2026, up 0.3 pp from a year earlier.
  • Other non-current assets increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether other non-current assets keeps rising in the next quarterly balance sheet after a +39.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
€296.47M+27.0% QoQ
Last fiscal yearDec 2025
€5.26B+631.1% YoY
Year agoJun 2025
€213.01M+39.2% since
Other Non-current Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+39.2%——
1 year+631.1%——
3-year CAGR+95.7%——
5-year CAGR——
10-year CAGR——

Other Non-current Assets history

EUR · from the balance sheet

Latest · FY2025
5.26B EUR
Year-over-year change
+631.1%
4-year CAGR
+43.5%

Other Non-current Assets vs competitors

How FMS compares with its peers on the latest reported figures

  • Peers report in different currencies, so other non-current assets is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +39.2% is the 3rd highest of 4, against a peer median of +54.3%.
  • Other non-current assets amounts to 0.9% of total assets for FMS, versus a peer median of 4.7%.
FMS Competitors
Other Non-current Assets for FMS and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
DVADaVita Inc.Jun 2026$298.54M USD+54.9%-7.9%1.7%
FMSFresenius Medical Care AG & Co. KGaAJun 2026€296.47M EUR+39.2%+95.7%0.9%
AKBAAkebia Therapeutics, Inc.Mar 2026$56.57M USD+54.3%+191.2%15.6%
TVTXTravere Therapeutics, Inc.Sep 2026$40.14M USD-5.0%-12.8%4.7%
Peer median (excluding FMS) —+54.3%-7.9%4.7%

Competitors are the stored peer set for FMS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents1.48B1.27B1.4B1.18B1.6B
Short-term Investments159.18M187.83M154.37M163.09M0
Net Receivables3.58B3.72B3.64B3.41B3.14B
Inventory2.04B2.3B2.18B2.07B2.14B
Other Current Assets672.58M682.6M1.28B1.06B1.02B
Total Current Assets7.97B8.2B8.7B7.92B7.9B
Property, Plant & Equipment (Net)8.55B8.34B7.45B7.26B3.01B
Goodwill14.36B15.79B14.65B15.17B0
Intangible Assets1.46B1.52B1.36B1.37B14.83B
Long-term Investments786.91M1.2B1.08B1.12B0
Tax Assets00000
Other Non-current Assets1.24B702.46M681.83M720.02M5.26B
Total Non-current Assets26.4B27.55B25.23B25.64B23.1B
Total Assets34.37B35.75B33.93B33.57B31B
Account Payables857.53M951.58M885.15M984.32M738M
Short-term Debt1.92B1.34B944.6M577.38M1.61B
Tax Payables265.13M267.87M331.86M282.64M0
Deferred Revenue518.03M105.72M85.82M82.17M0
Other Current Liabilities2.75B2.86B2.99B2.84B3.31B
Total Current Liabilities7.26B6.47B6.11B5.66B6.25B
Long-term Debt6.65B7.17B6.96B6.26B5.69B
Deferred Tax Liabilities868.45M936.48M750.29M708.89M0
Deferred Revenue (Non-current)09.47M13.87M34.02M0
Other Non-current Liabilities1.53B1.72B1.74B1.63B1.88B
Total Non-current Liabilities13.13B13.84B12.99B12.14B10.47B
Total Liabilities20.39B20.3B19.1B17.8B16.72B
Common Stock293M293.41M293.41M293.41M14.28B
Retained Earnings10.83B10.71B10.92B11.27B0
Accumulated OCI(1.31B)(388.47M)(975.17M)(328.55M)0
Other Stockholders Equity00000
Minority Interest1.28B1.46B1.21B1.19B0
Total Equity13.98B15.45B14.83B15.77B14.28B
Total Debt13.32B13.21B12.08B11B10.8B
Net Debt11.84B11.94B10.67B9.82B9.2B

Fresenius Medical Care AG & Co. KGaA

NYSE:FMS

Intrinsic Alpha fair value

Locked

Current Price

$20.95

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.